MD · Oncology · Hematology · Consulting
Combining clinical precision with a forward-thinking approach to cancer care, research collaboration, and healthcare innovation. Open to consulting, advisory, and speaking roles across pharma and medtech.
As a dual-trained oncologist and hematologist, I bring a uniquely integrated perspective to complex, overlapping presentations — and to the teams, companies, and research groups I work with.
Diagnosis and treatment of solid tumors, systemic therapy, targeted agents, and immunotherapy.
Management of blood cancers including leukemia, lymphoma, myeloma, and complex benign hematological conditions.
Available for consulting, advisory board participation, speaking engagements, and strategic collaboration with pharmaceutical, biotech, and healthcare organisations.
Clinical input on drug development, trial design, and indication strategy.
Independent clinical perspective for pharma and medtech panels.
Grounded in active clinical practice, my research interests span novel therapeutics, translational oncology, and real-world outcomes.
Patients can access active oncology and hematology trials.
Experience collaborating on sponsored research programmes.
Whether you're a pharmaceutical company exploring advisory input, a healthcare business seeking oncology expertise, or a conference seeking a speaker — I'd love to hear from you.